Kynam Capital Management »

Pharvaris N V shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $18M 640k 27.75
2025-09-30 $17M 675k 24.95

More positions owned by Kynam Capital Management

Cogent Biosciences (COGT)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Beam Therapeutics (BEAM)
BioCryst Pharmaceuticals (BCRX)
Miragen Therapeutics (VRDN)
Tyra Biosciences (TYRA)
Cg Oncology (CGON)
Cytomx Therapeutics (CTMX)
Nurix Therapeutics (NRIX)
Wave Life Sciences SHS (WVE)
Cullinan Oncology (CGEM)
Immunocore Hldgs Ads (IMCR)

View all positions for Kynam Capital Management

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Commodore Capital
Novo A/S
Wellington Management Company
Saturn V Capital Management
Cormorant Asset Management
5AM Venture Management
Sofinnova Ventures

View all funds holding Pharvaris N V